팝업레이어 알림

팝업레이어 알림이 없습니다.
본문 바로가기 주메뉴 바로가기 푸터 바로가기

SHAREDOC

모바일 메뉴
The Latest Videos
FexuQnA: How are Fexuclue and K-CAB different? FexuQnA: How are Fexuclue and K-CAB different? Watch Now
FexuQnA: How Does LPRD Compare to GERD in Terms of Recurrence, and How to Prevent them? FexuQnA: How Does LPRD Compare to GERD in Terms of Recurrence, and How to Prevent them? Watch Now
Latest Knowledge on GERD Treatment & Guidelines | Dr. Soo-Hyun Lee Latest Knowledge on GERD Treatment & Guidelines | Dr. Soo-Hyun Lee Watch Now
FEXUFORUM 2024 Live Replay
Fexuforum 2024: Treatment of H. pylori in Special Populations with Penicillin and Other Drug Allergies
Fexuforum 2024: Treatment of H. pylori in Special Populations with Penicillin and Other Drug Allergies 2024.11.21
Fexuforum 2024: Efficacy of Fexuprazan in Treating Erosive Esophagitis and NERD | Symptomatic and Mucosal Healing Outcomes
Fexuforum 2024: Efficacy of Fexuprazan in Treating Erosive Esophagitis and NERD | Symptomatic and Mucosal Healing Outcomes 2024.11.21
Fexuforum 2024: New Therapeutic Options with Fexuprazan
Fexuforum 2024: New Therapeutic Options with Fexuprazan 2024.11.21
Fexuforum 2024: Managing Difficulties to Treat GERD
Fexuforum 2024: Managing Difficulties to Treat GERD 2024.11.21
Conference ReCap
Tirzepatide for MASH with Liver Fibrosis
Tirzepatide for MASH with Liver Fibrosis 2024.11.01
Survodutide for People with MASH and Fibrosis
Survodutide for People with MASH and Fibrosis 2024.11.01
Post Colonoscopy Colorectal Cancer - From Assessing to Avoiding
Post Colonoscopy Colorectal Cancer - From Assessing to Avoiding 2024.11.01
ASGE: Management of Complex or Malignant Polyp (Case 2-3)
ASGE: Management of Complex or Malignant Polyp (Case 2-3) 2024.04.15
ASGE: Management of Complex or Malignant Polyp (Case 1)
ASGE: Management of Complex or Malignant Polyp (Case 1) 2024.04.11
Fexuclue 101: The Basics
FEXUCLUE: The New Wave of GERD Treatment (Clinical Standing and Global Status of Fexuclue)
FEXUCLUE: The New Wave of GERD Treatment (Clinical Standing and Global Status of Fexuclue) 2024.09.09
FEXUCLUE 101: Development History of Fexuprazan
FEXUCLUE 101: Development History of Fexuprazan 2024.09.04
FEXUCLUE 101: 6 Value Propositions of Fexuprazan
FEXUCLUE 101: 6 Value Propositions of Fexuprazan 2024.09.04
FEXUCLUE 101: How 5 Benefits of P-CAB Overcomes the Unmet Needs of PPI
FEXUCLUE 101: How 5 Benefits of P-CAB Overcomes the Unmet Needs of PPI 2024.09.04
FEXUCLUE 101: 5 Unmet Needs of PPI & Its Mechanism
FEXUCLUE 101: 5 Unmet Needs of PPI & Its Mechanism 2024.09.04
Fexuclue Case Studies (In Korea)
Cases of Fexuclue's Effect #6: Globus Treatment & QnA
Cases of Fexuclue's Effect #6: Globus Treatment & QnA 2024.06.13
Cases of Fexuclue's Effects #5: Increased Meal Compliance
Cases of Fexuclue's Effects #5: Increased Meal Compliance 2024.06.13
Cases of Fexuclue's Effect #4: Chronic Cough Improvement
Cases of Fexuclue's Effect #4: Chronic Cough Improvement 2024.06.13
Cases of Fexuclue's Effect #3: Night-time Acid Breakthrough (NAB) Control
Cases of Fexuclue's Effect #3: Night-time Acid Breakthrough (NAB) Control 2024.04.14
Cases of Fexuclue's Effect #2: Superior Heartburn Relief
Cases of Fexuclue's Effect #2: Superior Heartburn Relief 2024.04.14
Cases of Fexuclue's Effect #1: Full & Fast Onset
Cases of Fexuclue's Effect #1: Full & Fast Onset 2024.04.11
Fexuclue in Korean Internal Medicine Clinics
FexuQnA: How would you prescribe for patients also on DAPTs? Is DAPT+PPI recommendable?
FexuQnA: How would you prescribe for patients also on DAPTs? Is DAPT+PPI recommendable? 2024.09.09
FexuQnA: Is it necessary to follow the 4 week recommended prescription for Fexuclue?
FexuQnA: Is it necessary to follow the 4 week recommended prescription for Fexuclue? 2024.09.09
FexuQnA: How to treat GERD patients non-responsive to PPI? Would Fexuclue be effective?
FexuQnA: How to treat GERD patients non-responsive to PPI? Would Fexuclue be effective? 2024.09.09
FexuQnA: Among many acid suppressants (H2RA, PPI, P-CAB..), how do we decide which medication to use for which patient?
FexuQnA: Among many acid suppressants (H2RA, PPI, P-CAB..), how do we decide which medication to use for which patient? 2024.09.09
Latest Knowledge on GERD Treatment and Introduction to Fexuclue | Dr. Se-Jin Hwang
Latest Knowledge on GERD Treatment and Introduction to Fexuclue | Dr. Se-Jin Hwang 2024.04.11
PPI vs. P-CAB as Discussed by GI & ENT Doctors
FexuQnA: How would you treat patients presenting with GERD and Functional Dyspepsia symptoms?
FexuQnA: How would you treat patients presenting with GERD and Functional Dyspepsia symptoms? 2024.09.09
FexuQnA: Can I use Fexuclue instead of PPI to prevent ulcers or bleeding?
FexuQnA: Can I use Fexuclue instead of PPI to prevent ulcers or bleeding? 2024.09.09
FexuQnA: For Initial GERD Patients, Should I Choose PPI or P-CAB, and Why?
FexuQnA: For Initial GERD Patients, Should I Choose PPI or P-CAB, and Why? 2024.09.06
FexuQnA: What Is the Most Effective Treatment for Persistent Foreign Body Sensation (Globus)?
FexuQnA: What Is the Most Effective Treatment for Persistent Foreign Body Sensation (Globus)? 2024.09.06
Introduction to the New Wave of GERD Treatment, Fexuclue | Dr. Shin-Hyung Jo
Introduction to the New Wave of GERD Treatment, Fexuclue | Dr. Shin-Hyung Jo 2024.05.30
Strategies of LPRD Treatment with Fexuclue | Dr. Nam-Kook Kim
Strategies of LPRD Treatment with Fexuclue | Dr. Nam-Kook Kim 2024.05.30